Part,  Chapter, Paragraph

 1   II,     5.  1.  1|               low density lipoprotein cholesterol, high blood pressure, diabetes,
 2   II,     5.  1.  1|                elevated total and LDL cholesterol, low HDL cholesterol, hypertension,
 3   II,     5.  1.  1|              LDL cholesterol, low HDL cholesterol, hypertension, diabetes
 4   II,     5.  1.  1|           high blood pressure or high cholesterol;~· type 2 diabetes runs
 5   II,     5.  2.  2|               low density lipoprotein cholesterol, high blood pressure, diabetes,
 6   II,     5.  2.  2|                elevated total and LDL cholesterol, low HDL cholesterol, hypertension,
 7   II,     5.  2.  2|              LDL cholesterol, low HDL cholesterol, hypertension, diabetes
 8   II,     5.  2.  3|           risk factors, such as serum cholesterol and blood pressure, and
 9   II,     5.  2.  4|              pressure, obesity, blood cholesterol and tobacco use would more
10   II,     5.  2.  4|               pressure, LDL and total cholesterol, physical inactivity and
11   II,     5.  2.  4|       incidence (age, blood pressure, cholesterol, body mass index) and the
12   II,     5.  2.  4|               2.8 shows data on total cholesterol: prevalence of hypercholesterolemia
13   II,     5.  2.  4|        Estimated mean values of total cholesterol in mmol/l and prevalence
14   II,     5.  2.  4|        high-density lipoprotein (HDL) cholesterol and glycaemia (Panico et
15   II,     5.  2.  4|   participating countries and also in cholesterol in many of them. According
16   II,     5.  2.  4|          blood pressure (mmHg), total cholesterol (mmol/L) and BMI (Kg/m2 )
17   II,     5.  2.  5|              systolic blood pressure, cholesterol and diabetes considered
18   II,     5.  2.  5|             treatment targets for LDL cholesterol and blood pressure in individuals
19   II,     5.  2.  5|               foods rich in preformed cholesterol, a moderate intake of salt
20   II,     5.  2.  5|           were documented in smoking, cholesterol and blood pressure. By 1992,
21   II,     5.  2.  6|        factors such as smoking habit, cholesterol, blood pressure, obesity
22   II,     5.  2.  6|       progress and outcomes.~ ~Plasma cholesterol levels and CVD risk~Observational
23   II,     5.  2.  6|         average level of total plasma cholesterol in different countries is
24   II,     5.  2.  6|            association between plasma cholesterol levels and CHD risk was
25   II,     5.  2.  6|           extends to values of plasma cholesterol well below those usually
26   II,     5.  2.  6|               80s, that total and LDL cholesterol reduction causes a reduction
27   II,     5.  2.  6|               reduction of plasma LDL cholesterol levels by 1% will induce
28   II,     5.  2.  6|     association of stroke with plasma cholesterol levels is weak, or absent,
29   II,     5.  2.  6|            mechanistic point of view, cholesterol reduction has been shown
30   II,     5.  2.  6|              useful to control plasma cholesterol levels and the availability
31   II,     5.  2.  6|              of drugs able to inhibit cholesterol synthesis and absorption
32   II,     5.  2.  6|            therapeutic target (plasma cholesterol levels ranging from 70 mg/
33   II,     5.  2.  6|           Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT)
34   II,     5.  2.  6|          Studies Collaboration: Blood cholesterol and vascular mortality by
35   II,     5.  2.  6|               statins: benefit beyond cholesterol reduction? A meta-regression
36   II,     5.  2.  6|            relationship between serum cholesterol and risk of premature death
37   II,     5.  2.  7|               trials for the National Cholesterol Education Program Adult
38   II,     5.  2.  7| Non-pharmacological control of plasma cholesterol levels. Nutr Metab Cardiovasc
39   II,     5.  4.  1|       increased blood levels of total cholesterol and triglycerides. High
40   II,     5.  4.  2|              HbA1c testing~Annual LDL cholesterol testing~Annual screening
41   II,     5.  4.  2|             last 12 months with total cholesterol>5 mmol/l~14~Percent of diabetic
42   II,     5.  4.  2|           level.~Measurement of total cholesterol in the last 12 months is
43   II,     5.  4.  2|       population that had their total cholesterol tested in the last 12 months.~
44   II,     5.  4.  2|             the last 12 months.~Total cholesterol level>5 mmol/l is an important
45   II,     5.  4.  2|           population with their total cholesterol tested in last 12 months
46   II,     5.  4.  2|             12 months showing a total cholesterol above 5 mmol/l.~Measurement
47   II,     5.  4.  2|            mmol/l.~Measurement of LDL cholesterol in the last 12 months is
48   II,     5.  4.  2|               the last 12 months.~LDL cholesterol level >2.6 mmol/l is an
49   II,     5.  4.  2|            mmol/l.~Measurement of HDL cholesterol in the last 12 months is
50   II,     5.  4.  2|               the last 12 months.~HDL cholesterol level <1.0 mmol/l for men
51   II,     5.  4.  2|            the last 12 months and HDL cholesterol below 1.0 for men and 1.
52   II,     5.  4.  2|           population with their total cholesterol tested in last 12 months
53   II,     5.  4.  2|             12 months showing a total cholesterol above 2.3 mmol/l.~Microalbuminuria
54   II,     5.  4.  3|             age.~Measurement of total cholesterol in the last 12 months. EUCID
55   II,     5.  4.  3|            median value of 87%.~Total cholesterol level>5 mmol/l. In EUCID
56   II,     5.  4.  3|        percentage.~Measurement of LDL cholesterol in the last 12 months. The
57   II,     5.  4.  3|             the treatment of elevated cholesterol is based on total and HDL
58   II,     5.  4.  3|             is based on total and HDL cholesterol. The decrease in patients
59   II,     5.  4.  3|      recommendations for testing.~LDL cholesterol level >2.6 mmol/l. Crude
60   II,     5.  4.  3|            effect.~Measurement of HDL cholesterol in the last 12 months. The
61   II,     5.  4.  3|              and people above 65.~HDL cholesterol level <1.0 mmol/l for men
62   II,     5.  4.  5|           high blood pressure or high cholesterol;~- type 2 diabetes familiarity;~-
63   II,     5.  4.  6|               blood pressure and high cholesterol, see Chapter 5.2.4. and
64   II,     5. 13    |            blood pressure, high blood cholesterol level, high BMI, low fruit
65   II,     9.  2.  3|           adiposity, raised HDL blood cholesterol, raised blood triglycerides,
66   II,     9.  3.  1|           growing that lowering blood cholesterol levels and treating severe
67  III,    10.  1    |             particles~food, e.g. high cholesterol~stress~ ~Respiratory diseases,
68  III,    10.  2.  1|  cardiovascular disease, such as high cholesterol levels in blood and hypertension (
69  III,    10.  2.  1|            blood pressure, high blood cholesterol level, high BMI, low fruit
70  III,    10.  2.  1|               low-density lipoprotein cholesterol, a low level of high-density
71  III,    10.  2.  1|              high-density lipoprotein cholesterol and a high gestational weight
72  III,    10.  2.  1|               fibre” and “helps lower cholesterol”) on foodstuffs based on
73  III,    10.  2.  2|                        10.2.2. Plasma cholesterol levels.~ ~Observational
74  III,    10.  2.  2|         average level of total plasma cholesterol in different countries is
75  III,    10.  2.  2|            association between plasma cholesterol levels and CHD risk was
76  III,    10.  2.  2|           extends to values of plasma cholesterol well below those usually
77  III,    10.  2.  2|              increase in plasma total cholesterol is associated with an increase
78  III,    10.  2.  2|             reduction in plasma total cholesterol is followed by a 25% reduction
79  III,    10.  2.  2|             in populations with total cholesterol less than 3-4 mmol/l (~
80  III,    10.  2.  2|               reduction of plasma LDL cholesterol levels by 1% will induce,
81  III,    10.  2.  2|     association of stroke with plasma cholesterol levels is weak, or absent,
82  III,    10.  2.  2|            mechanistic point of view, cholesterol reduction has been shown
83  III,    10.  2.  2|              useful to control plasma cholesterol levels as well as the availability
84  III,    10.  2.  2|              of drugs able to inhibit cholesterol synthesis and absorption
85  III,    10.  2.  2|            therapeutic target (plasma cholesterol levels ranging from 70 mg/
86  III,    10.  3.  2|             particles~food, e.g. high cholesterol~stress~ ~Respiratory diseases,
87   IV,    11.  1.  5|            patient blood pressure and cholesterol targets in the UK GP contract,
88   IV,    12.  2    |             treatment targets for LDL cholesterol and blood pressure in individuals
89   IV,    12.  2    |               foods rich in preformed cholesterol, a moderate intake of salt
90   IV,    12.  2    |           were documented in smoking, cholesterol and blood pressure. By 1992,
91   IV,    12.  2    |               blood pressure and high cholesterol. Because of the increase
92   IV,    12. 10    |                Hypertension, Obesity, Cholesterol, Cancer, AIDS, Diabetes
93   IV,    13.  2.  3|   hypertension, 7.4% and 7.4% to high cholesterol and obesity. Worldwide,
94   IV,    13.  2.  4|      overweight, high blood levels of cholesterol and physically inactivity.
95  Key,   Ap5.  0.  0|           children~chlamydia~chloride~cholesterol~chromium~cigarette~cigarettes~